Keiji Fujiwara

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Multidrug Resistant

Community Dwelling

Pulmonary Hypertension

Genetic Diversity

Top Venues

Microbiology spectrum

ERJ open research

Antimicrobial agents and chemotherapy

This page only lists publications with an associated author ORCID identifier.

Publications

Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Kosaku Komiya, Satoshi Mitarai
In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum 12 (7) (2024)
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Kosaku Komiya, Satoshi Mitarai
In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum 12 (7) (2024)
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Kosaku Komiya, Satoshi Mitarai
In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum 12 (7) (2024)
Izumi Yamatani, Akio Aono, Keiji Fujiwara, Takahiro Asami, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Kosaku Komiya, Satoshi Mitarai
In vitro effects of the new oral β-lactamase inhibitor xeruborbactam in combination with oral β-lactams against clinical Mycobacterium abscessus isolates. Microbiology spectrum (2024)
Keiji Fujiwara, Akio Aono, Takahiro Asami, Kozo Morimoto, Keisuke Kamada, Yuta Morishige, Yuriko Igarashi, Kinuyo Chikamatsu, Yoshiro Murase, Hiroyuki Yamada, Akiko Takaki, Satoshi Mitarai
In Vitro Synergistic Effects of Omadacycline with Other Antimicrobial Agents against Mycobacterium abscessus. Antimicrobial agents and chemotherapy (2023)
Kozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, Masashi Ito, Fumiko Uesugi, Takanori Asakura, Takeshi Osawa, Koji Furuuchi, Atsuyuki Kurashima, Keiji Fujiwara, Naoki Hasegawa, Yoshiaki Tanaka, Kudoh Shoji, Yuji Shiraishi, Satoshi Mitarai, Manabu Ato, Ken Ohta
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ open research 9 (1) (2023)
Kozo Morimoto, Kazuro Iwai, Takashi Yoshiyama, Masashi Ito, Fumiko Uesugi, Takanori Asakura, Takeshi Osawa, Koji Furuuchi, Atsuyuki Kurashima, Keiji Fujiwara, Naoki Hasegawa, Yoshiaki Tanaka, Kudoh Shoji, Yuji Shiraishi, Satoshi Mitarai, Manabu Ato, Ken Ohta
Epidemiological characteristics of nontuberculous mycobacteriosis and bronchiectasis: comparative study using national mortality statistics from 1970 to 2015 in Japan. ERJ open research 9 (1) (2023)
Keiji Fujiwara, Mitsunori Yoshida, Yoshiro Murase, Akio Aono, Koji Furuuchi, Yoshiaki Tanaka, Ken Ohta, Manabu Ato, Satoshi Mitarai, Kozo Morimoto
Potential Cross-Transmission of Mycobacterium abscessus among Non-Cystic Fibrosis Patients at a Tertiary Hospital in Japan. Microbiology spectrum 10 (3) (2022)
Fumiya Watanabe, Koji Furuuchi, Kazuhiko Hanada, Keiji Fujiwara, Fumiko Uesugi, Miyako Hiramatsu, Takashi Yoshiyama, Yuji Shiraishi, Atsuyuki Kurashima, Ken Ohta, Kozo Morimoto
Pharmacokinetics and Adverse Effects of Clofazimine in the Treatment of Pulmonary Non-Tuberculous Mycobacterial Infection. Antimicrobial agents and chemotherapy 66 (8) (2022)